268
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Addiction Treatment Outcomes: Examining the Impact of an Inpatient Program for Substance Use Disorders and Concurrent Mental Distress

, MAORCID Icon, , MAORCID Icon, , PhD & , PhD

References

  • Addictions and Mental Health Ontario. (2019, June 3). Residential treatment of adult substance use disorders position paper. Retrieved October 18, 2022, from https://amho.ca/wp-content/uploads/Residential-Treatment-of-Adult-Substance-Use-Disorders-Position-Paper.pdf
  • Beckstead, D. J., Hatch, A. L., Lambert, M. J., Eggett, D. L., Goates, M. K., & Vermeersch, D. A. (2003). Clinical significance of the Outcome Questionnaire (OQ-45.2). The Behavior Analyst Today, 4(1), 86. https://doi.org/10.1037/h0100015
  • Bischoff, T., Anderson, S., Heafner, J., & Tambling, R. (2020). Establishment of a Reliable Change Index for the GAD-7. Psychology, Community & Health, 8(1), 176–187. https://doi.org/10.5964/pch.v8i1.309
  • Bischof, G., Rumpf, H.-J., & John, U. (2012). Natural recovery from addiction. In H. Shaffer, D. A. LaPlante, & S. E. Nelson (Eds.), APA addiction syndrome handbook (Vol. 2, pp. 133–155). American Psychological Association. https://doi.org/10.1037/13750-006.
  • Blanchard, E. B., Jones-Alexander, J., Buckley, T. C., & Forneris, C. A. (1996). Psychometric properties of the PTSD checklist (PCL). Behavioral Research and Therapy, 34(8), 669–673. https://doi.org/10.1016/0005-7967(96)00033-2
  • British Columbia Centre on Substance Use (BCCSU). (December. 2019). Provincial guideline for the clinical management of high-risk drinking and alcohol use disorder. BC Ministry of Health and BC Ministry of Mental Health and Addictions. https://www.bccsu.ca/wp-content/uploads/2019/12/AUD-Guideline.pdf
  • British Columbia & Ministry of Health. (2011). Service model and provincial standards for adult residential substance use services. Victoria, BC.
  • Canadian Centre on Substance Use and Addiction. (2022). Canadian Substance Use Costs and Harms. https://www.ccsa.ca/canadian-substance-use-costs-and-harms
  • Canadian Substance Use Costs and Harms Scientific Working Group. (2018). Canadian Substance Use Costs and Harms (2007–2014). (Prepared by the Canadian Institute for Substance Use Research and the Canadian Centre on Substance Use and Addiction). Canadian Centre on Substance Use and Addiction.). Retrieved October 18, 2022, from https://ccsa.ca/sites/default/files/2019-04/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2018-en.pdf
  • Center for Substance Abuse Treatment. A Guide to Substance Abuse Services for Primary Care Clinicians. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). (1997). (Treatment Improvement Protocol (TIP) Series, No. 24.) Chapter 5—Specialized Substance Abuse Treatment Programs. https://www.ncbi.nlm.nih.gov/books/NBK64815/
  • Connery, H. S., McHugh, R. K., Reilly, M., Shin, S., & Greenfield, S. F. (2020). Substance use disorders in global mental health delivery: Epidemiology, Treatment Gap, and implementation of evidence-based treatments. Harvard Review of Psychiatry, 28(5), 316–327. https://doi.org/10.1097/HRP.0000000000000271
  • Costello, M. J., Ropp, C., Sousa, S., Woo, W., Vedelago, H., & Rush, B. (2016). The development and implementation of an outcome monitoring system for addiction treatment. The Canadian Journal of Addiction, 7(3), 15–24. https://doi.org/10.1097/02024458-201609000-00003
  • Dice, R. (2020). A Meta-Analysis of Group Treatment Outcomes for Veterans with Substance Use Disorders [ Doctor of Philosophy (PhD), Dissertation]. Counseling & Human Services, Old Dominion University. https://doi.org/10.25777/2dhw-s066. https://digitalcommons.odu.edu/chs_etds/124
  • Donovan, B., Padin-Rivera, E., & Kowaliw, S. (2001). “Transcend”: Initial outcomes from a post-traumatic stress disorder/substance abuse treatment program. International Society for Traumatic Stress Studies, 14(4), 757–772. https://doi.org/10.1023/A:1013094206154
  • Elmquist, J., Shorey, R. C., Anderson, S. E., & Stuart, G. L. (2016). The relationship between generalized anxiety symptoms and treatment dropout among women in residential treatment for substance use disorders. Substance Use & Misuse, 51(7), 835–839. https://doi.org/10.3109/10826084.2016.1155612
  • Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment, 43(1), 36–47. https://doi.org/10.1016/j.jsat.2006.11.013
  • Garke, M. Å., Isacsson, N. H., Sörman, K., Bjureberg, J., Hellner, C., Gratz, K. L., Berghoff, C. R., Sinha, R., Tull, M. T., & Jayaram-Lindström, N. (2021). Emotion dysregulation across levels of substance use. Psychiatry Research, 296, 113662. https://doi.org/10.1016/j.psychres.2020.113662
  • Garner, B. R. (2009). Research on the diffusion of evidence-based treatments within substance abuse treatment: A systematic review. Journal of Substance Abuse Treatment, 36(4), 376–399. https://doi.org/10.1016/j.jsat.2008.08.004
  • Ghee, C. A., Bolling, L. C., & Johnson, C. S. (2009). The efficacy of a condensed seeking safety intervention for women in residential chemical dependence treatment at 30 days posttreatment. Journal of Child Sexual Abuse, 18(5), 475–488. https://doi.org/10.1090/10538710903183287
  • Hien, D. A., Levin, F. R., Ruglass, L. M., López-Castro, T., Papini, S., Hu, M.-C., Cohen, L. R., & Herron, A. (2015). Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 83(2), 359–369. https://doi.org/10.1037/a0038719
  • Khalili, P., Nadimi, A. E., Baradaran, H. R., Janani, L., Rahimi-Movaghar, A., Rajabi, Z., Rahmani, A., Hojati, Z., Khalagi, K., & Motevalian, S. A. (2021). Validity of self-reported substance use: Research setting versus primary health care setting. Substance Abuse Treatment, Prevention, and Policy, 16(1), 66. https://doi.org/10.1186/s13011-021-00398-3
  • Krentzman, A. R., Robinson, E. A. R., Moore, B. C., Kelly, J. F., Laudet, A. B., White, W. L., Zemore, S. E., Kurtz, E., & Strobbe, S. (2011). How Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) work: Cross-disciplinary perspectives. Alcoholism Treatment Quarterly, 29(1), 75–84. https://doi.org/10.1080/07347324.2011.538318.
  • Kroenke, K. (2012). Enhancing the clinical utility of depression screening. Canadian Medical Association Journal, 184(3), 281–282. https://doi.org/10.1503/cmaj.112004
  • Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  • Lambert, M. J. (2015). Progress feedback and the OQ-system: The past and the future. psychotherapy. Psychotherapy ( Chicago, Ill), 52(4), 381–390. https://doi.org/10.1037/pst0000027
  • Lambert, M. J., Gregersen, A. T., & Burlingame, G. M. (2004). The outcome questionnaire-45. In M. E. Maruish (Ed.), The use of psychological testing for treatment planning and outcomes assessment: Instruments for adults (pp. 191–234). Lawrence Erlbaum Associates Publishers.
  • Long, C. G., Williams, M., & Hollin, C. R. (1998). Treating alcohol problems: A study of programme effectiveness and cost effectiveness according to length and delivery of treatment. Addiction (Abingdon, England), 93(4), 561–571. https://doi.org/10.1046/j.1360-0443.1998.93456111.x
  • Magill, M., Tonigan, J. S., Kiluk, B., Ray, L., Walthers, J., & Carroll, K. (2020). The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review. Behaviour Research and Therapy, 131, 103648.
  • Matthews, S., Dwyer, R., & Snoek, A. (2017). Stigma and self-stigma in addiction. Journal of Bioethical Inquiry, 14(2), 275–286. https://doi.org/10.1007/s11673-017-9784-y
  • May, J., Andrade, J., Kavanagh, D. J., Feeney, G. F., Gullo, M. J., Statham, D. J., Skorka-Brown, J., Connolly, J. M., Cassimatis, M., Young, R. M., & Connor, J. P. (2014). The craving experience questionnaire: A brief, theory-based measure of consummatory desire and craving. Addiction, 109(5), 728–735. https://doi.org/10.1111/add.12472
  • McLellan, A. T., Gutman, M., Lynch, K., McKay, J. R., Ketterlinus, R., Morgenstern, J., & Woolis, D. (2003). One-year outcomes from the CASAWORKS for families intervention for substance-abusing women on welfare. Evaluation Review, 27(6), 656–680. https://doi.org/10.1177/0193841X03259029
  • McQuaid, R. J., Malik, A., Moussouni, K., Baydack, N., Stargardter, M., & Morrisey, M. (2017). Life in recovery from addiction in Canada. Canadian Centre on Substance Use and Addiction.
  • Mental Health Commission of Canada. (2011). Making the Case for Investing in Mental Health in Canada. https://www.mentalhealthcommission.ca/wp-content/uploads/drupal/2016-06/Investing_in_Mental_Health_FINAL_Version_ENG.pdf
  • Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., DeWit, D. J., Kolody, B., Vega, W. A., Wittchen, H. U., & Kessler, R. C. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors, 23(6), 893–907. https://doi.org/10.1016/S0306-4603(98)00076-8
  • Mueser, K. T., Drake, R. E., Turner, W., & McGovern, M. (2006). Comorbid substance use disorders and psychiatric disorders. In K. M. Carroll & W. R. Miller (Eds.), Rethinking substance abuse: What the science shows, and what we should do about it (pp. 115–133). Guilford Press.
  • National Treatment Strategy Working Group. (2008). National Framework for Action to Reduce the Harms Associated with Alcohol and Other Drugs and Substances in Canada.
  • Pearson, C., Janz, T., & Ali, J. (2013). Mental and substance use disorders in Canada - Health at a Glance. Statistics Canada Catalogue no. 82-624-X https://www150.statcan.gc.ca/n1/en/pub/82-624-x/2013001/article/11855-eng.pdf?st=mQtcOYLj
  • Public Health Agency of Canada. (2022). Joint statement from the Co-chairs of the Special Advisory Committee on the epidemic of opioid overdoses – Latest National Data on Substance-Related Harms. https://www.canada.ca/en/public-health/news/2022/06/joint-statement-from-the-co-chairs-of-the-special-advisory-committee-on-the-epidemic-of-opioid-overdoses--latest-national-data-on-substance-related0.html
  • Public Health Ontario. (2021). Opioid related morbidity and mortality in Ontario. Ontario Agency for Health Protection and Promotion. https://www.publichealthontario.ca/en/data-and-analysis/substance-use/interactive-opioid-tool
  • Raistrick, D., Bradshaw, J., Tober, G., Weiner, J., Allison, J., & Healey, C. (1994). Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction, 89(5), 563–572. https://doi.org/10.1111/j.1360-0443.1994.tb03332.x
  • Raistrick, D., Tober, G., Sweetman, J., Unsworth, S., Crosby, H., & Evans, T. (2014). Measuring clinically significant outcomes - LDQ, CORE-10 and SSQ as dimension measures of addiction. Psychiatric Bulletin, 38(3), 112–115. https://doi.org/10.1192/pb.bp.112.041301
  • Rush, B. R., Urbanoski, K. A., Bassani, D. G., Castel, S., & Wild, T. C. (2010). The epidemiology of co-occurring substance use and other mental disorders in Canada: Prevalence, service use, and unmet needs. In J. Cairney & D. L. Streiner (Eds.), Mental disorder in Canada: An epidemiological perspective (pp. 170–204). University of Toronto Press. https://doi.org/10.3138/9781442698574-010
  • Schäfer, I., & Najavits, L. M. (2007). Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse. Current Opinion in Psychiatry, 20(6), 614–618. https://doi.org/10.1097/yco.0b013e3282f0ffd9
  • Schneekloth, T. D., Biernacka, J. M., Hall-Flavin, D. K., Karpyak, V. M., Frye, M. A., Loukianova, L. L., Stevens, S. R., Drews, M. S., Geske, J. R., & Mrazek, D. A. (2012). Alcohol craving as a predictor of relapse. The American Journal on Addictions, 21(s1), S20–S26. https://doi.org/10.1111/j.1521-0391.2012.00297.x
  • Schulte, S. J., Meier, P. S., Stirling, J., & Berry, M. (2010). Unrecognised dual diagnosis - a risk factor for dropout of addiction treatment. Mental Health and Substance Use: Dual Diagnosis, 3(2), 94–109. https://doi.org/10.1080/17523281003705199
  • Select Standing Committee on Health. (2022, November). Closing gaps, reducing barriers: Expanding the response to the toxic drug and overdose crisis. https://www.leg.bc.ca/content/CommitteeDocuments/42nd-parliament/3rd-session/health/report/SSC-Health-Report_42-3_2022-11-01_Final.pdf
  • Simpson, D. D. (1979). The relation of time spent in drug abuse treatment to posttreatment outcome. The American Journal of Psychiatry, 136(11), 1449–1453. https://doi.org/10.1176/ajp.136.11.1449
  • Snaychuk, L. A., Hirst, S. A., & Basedow, C. A. (2023). Inpatient treatment for substance use disorders: Reductions in substance cravings, anxiety, and depressive symptoms. Journal of Substance Use, 1–7. https://doi.org/10.1080/14659891.2023.2173095
  • Spitzer, R. L., Kroenke, K., Williams, J., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
  • Statistics Canada. (2012). Mental and substance use disorders in Canada. Statistics Canada Catologue, No. 82-624-X. Version updated November 2015.
  • Statistics Canada. (2014). Uniform crime reporting survey. https://www150.statcan.gc.ca/n1/pub/85-002-x/2015001/article/14211-eng.htm
  • Statistics Canada. (2018). The Daily — Canadian Community Health Survey, 2018. Statcan.gc.ca. https://www150.statcan.gc.ca/n1/daily-quotidien/190625/dq190625b-eng.htm
  • Stellern, J., Xiao, K. B., Grennell, E., Sanches, M., Gowin, J. L., & Sloan, M. E. (2022). Emotion regulation in substance use disorders: A systematic review and meta‐analysis. Addiction, 118(1), 30–47. https://doi.org/10.1111/add.16001
  • Stohs, M. E., Schneekloth, T. D., Geske, J. R., Biernacka, J. M., & Karpyak, V. M. (2019). Alcohol craving predicts relapse after residential addiction treatment. Alcohol and Alcoholism, 54(2), 167–172. https://doi.org/10.1093/alcalc/agy093
  • Substance Abuse and Mental Health Services Administration. (2021). National Survey on Drug Use and Health. United Stated Department of Health and Human Services’. https://www.hhs.gov/about/news/2023/01/04/samhsa-announces-national-survey-drug-use-health-results-detailing-mental-illness-substance-use-levels-2021.html#:~:text=Drug%20Use%20and%20Substance%20Use,drugs%20in%20the%20past%20year.
  • Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Sampson, N., & Kessler, R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the national comorbidity survey. Addiction (Abingdon, England), 105(6), 1117–1128. https://doi.org/10.1111/j.1360-0443.2010.02902.x
  • Syan, S. K., Minhas, M., Oshri, A., Costello, J., Sousa, S., Samokhvalov, A. V., Rush, B., & MacKillop, J. (2020). Predictors of premature treatment termination in a large residential addiction medicine program. Journal of Substance Abuse Treatment, 117, 108077. https://doi.org/10.1016/j.jsat.2020.108077
  • Thompson, K., Dutton, D. J., McNabb, K., Liu, T., Blades, S., & Asbridge, M. (2021). Changes in alcohol consumption during the COVID-19 pandemic: Exploring gender differences and the role of emotional distress. Health Promotion and Chronic Disease Prevention in Canada, 41(9), 254–263. https://doi.org/10.24095/hpcdp.41.9.02
  • Tiet, Q. Q., Ilgen, M. A., Byrnes, H. F., Harris, A. H., & Finney, J. W. (2007). Treatment setting and baseline substance use severity interact to predict patients’ outcomes. Addiction (Abingdon, England), 102(3), 432–440. https://doi.org/10.1111/j.1360-0443.2006.01717.x
  • Toftdahl, N. G., Nordentoft, M., & Hjorthøj, C. (2015). Prevalence of substance use disorders in psychiatric patients: A nationwide Danish population-based study. Social Psychiatry & Psychiatric Epidemiology, 51(1), 129–140. https://doi.org/10.1007/s00127-015-1104-4
  • UNODC. (2019). World drug report 2019. United Nations Office on Drugs and Crime. https://www.unodc.org/unodc/press/releases/2020/June/media-advisory—global-launch-of-the-2020-world-drug-report.html
  • Victor, S. E., & Klonsky, E. D. (2016). Validation of a brief version of the Difficulties in Emotion Regulation Scale (DERS-18) in five samples. Journal of Psychopathology and Behavioral Assessment, 38(4), 582–589. https://doi.org/10.1007/s10862-016-9547-9
  • Vujanovic, A. A., Meyer, T. D., Heads, A. M., Stotts, A. L., Villarreal, Y. R., & Schmitz, J. M. (2017). Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches. The American Journal of Drug and Alcohol Abuse, 43(4), 402–415. https://doi.org/10.1080/00952990.2016.1199697
  • Wallace, A. E., & Weeks, W. B. (2004). Substance abuse intensive outpatient treatment: Does program graduation matter? Journal of Substance Abuse Treatment, 27(1), 27–30. https://doi.org/10.1016/j.jsat.2004.03.006
  • Warner, N., & Murphy, M. (2022). Dialectical behaviour therapy skills training for individuals with substance use disorder: A systematic review. Drug and Alcohol Review, 41(2), 501–516. https://doi.org/10.1111/dar.13362
  • Weathers, F. W., Litz, B. T., Herman, D. S., Huska, J. A., & Keane, T. M. (1993) The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Annual Convention of the International Society for Traumatic Stress Studies, San Antonio.
  • Weiss, N. H., Kiefer, R., Goncharenko, S., Raudales, A. M., Forkus, S. R., Schick, M. R., & Contractor, A. A. (2022). Emotion regulation and substance use: A meta-analysis. Drug and Alcohol Dependence, 230, 109131. https://doi.org/10.1016/j.drugalcdep.2021.109131

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.